Virdev Intermediates Private Limited

Virdev Intermediates Private Limited - pharma in Surat, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ1994PTC021189 Incorporated 01 February 1994 ROC Ahmedabad HQ Surat, Gujarat, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹107.72 Cr
▼ 3% YoY
Net profit · FY 2025
₹8.71 Cr
Net margin 8.1%
EBITDA · FY 2025
₹16.95 Cr
EBITDA margin 15.7%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹5.41 Cr
Issued & subscribed
Satisfied charges
₹92.47 Cr
No open charges
Company age
32 yrs
Est. 1994
Employees · EPFO
334
Provident fund records

About Virdev Intermediates Private Limited

Data last updated:

Virdev Intermediates Private Limited is a private limited company based in Surat, Gujarat, India, a subsidiary of Bdr Pharmaceuticals International Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 01 February 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1994PTC021189. Its GSTIN is 24AAACV8038L1Z2 (Gujarat).

The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹5.41 Cr. It is led by directors including Kaushik Bhagwandas Jariwala and Narendra Bhagwandas Jariwala.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S No 33/1 – A Plot No – 1 Khatodara B/H Sub Jail Surat, Gujarat, India – 395002.

As per the financials filed for FY 2025, the company reported a revenue of ₹107.72 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹8.71 Cr (net margin 8.1%) and EBITDA of ₹16.95 Cr (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 21% over five years.

The company has about 334 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: BDR Pharmaceuticals Internationals. As per MCA filings, the company has satisfied charges of ₹92.47 Cr on record. Court records list 18 cases involving the company, including 4 filed by the company and 14 filed against it; 3 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹20.12 Cr; the latest was in July 2018. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Bakul Pharma Private Limited with revenue of ₹110.31 Cr. The company has 20 MSME Form 1 returns on record between 2015 and 2023, listing 2,196 overdue payments to 156 micro and small suppliers.

Virdev Intermediates Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0001601). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bdrpharma.com.

Company details

CIN U24230GJ1994PTC021189
Registration Number 021189
Incorporation Date 01 February 1994
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Bdr Pharmaceuticals International Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-22-0001601

Recognitions & Rankings of Virdev Intermediates

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-22-0001601

Contact details

Virdev Intermediates Private Limited's registered office is in Surat, Gujarat. Its website is bdrpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    S No 33/1 – A Plot No – 1 Khatodara B/H Sub Jail Surat, Gujarat, India – 395002
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Virdev Intermediates Private Limited, buy the company report.

Comprehensive company report
Virdev Intermediates Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Virdev Intermediates operates one associated brand: BDR Pharmaceuticals Internationals. Each brand links to its own profile.

BrandDescriptionWebsite
APIs and finished products are developed and manufactured.bdrpharma.com

Business activity

The main business activity of Virdev Intermediates is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Virdev Intermediates Private Limited, buy the company report.

Financials of Virdev Intermediates Private Limited

FY 2025 filings available

Virdev Intermediates Private Limited reported revenue of ₹107.72 Cr (down 3% YoY) for FY 2025.

Revenue · FY 2025
₹107.72 Cr ▼ 3%
Net profit · FY 2025
₹8.71 Cr margin 8.1%
EBITDA · FY 2025
₹16.95 Cr margin 15.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 2%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 5%
5 years · compounded
▲ 40%

Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹16.95 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8.71 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin15.7%
Net Profit Margin8.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Virdev Intermediates Private Limited, buy the company report.

Board of directors of Virdev Intermediates Private Limited

Virdev Intermediates has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kaushik Bhagwandas JariwalaDirector12 Nov 200025 Years 11 MonthsCurrent
Narendra Bhagwandas JariwalaDirector01 Feb 199432 Years 9 MonthsCurrent
Sanjay Amritlal SolankiDirector12 Nov 200025 Years 11 MonthsCurrent
Viralkumar Narendrabhai JariwalaDirector12 Nov 200025 Years 11 MonthsCurrent
Dheer Dharmesh ShahDirector01 Mar 20242 Years 8 MonthsCurrent
Raheel Dharmesh ShahDirector27 Jul 20188 Years 3 MonthsCurrent

Peer comparison

Virdev Intermediates Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Bakul Pharma Private Limited₹110.31 Cr (FY 2025)-21.0%Mumbai, Maharashtra, India
Danopharm Private Limited₹108.78 Cr (FY 2025)-7.0%Mumbai, Maharashtra, India
Almelo Private Limited₹108.05 Cr (FY 2024)22.0%Hyderabad, Telangana, India
Virdev Intermediates Private Limitedthis company₹107.72 Cr (FY 2025)₹8.71 Cr8.1%-3.0%334Surat, Gujarat, India
Panchsheel Organics Limited₹107.68 Cr (FY 2024)3.0%Indore, Madhya Pradesh, India
Patel Chem Specialities Limited₹105.55 Cr (FY 2025)28.0%Ahmedabad, Gujarat, India
Lucent Drugs Private Limited₹104.13 Cr (FY 2025)101.0%Sanathnagar, Telangana, India
Novo Excipients Private Limited₹103.54 Cr (FY 2025)-1.0%Mumbai, Maharashtra, India
Par Active Technologies Private Limited₹103.46 Cr (FY 2025)2.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Virdev Intermediates Private Limited, buy the company report.

Auditor

Virdev Intermediates Private Limited is audited by M. R. BOMBAYWALA & CO. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
M. R. BOMBAYWALA & CO.FY 2022123117W

Shareholding

The shareholding of Virdev Intermediates Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Virdev Intermediates Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹92.47 Cr
Breakdown by lending institutions
Central Bank of India₹33.60 Cr
Kotak Mahindra Bank Limited₹23.09 Cr
State Bank of India₹19.50 Cr
Ing Vysya Bank Limited₹16.06 Cr
The Federal Bank Ltd₹0.22 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Mar 201510569075Kotak Mahindra Bank Limited₹4.9 CrSatisfied
31 Jul 201410515182Kotak Mahindra Bank Limited₹18.19 CrSatisfied
18 Jul 201410516190Ing Vysya Bank Limited₹16.06 CrSatisfied
30 Jul 201310449122Central Bank of India₹1.9 CrSatisfied
23 Mar 200710048117Central Bank of India₹12 CrSatisfied

To see the full charge records of Virdev Intermediates Private Limited, buy the company report.

Total charge records: 10 View all charges

Deals & funding

Virdev Intermediates Private Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹20.12 Cr; the latest was in July 2018.

Total deals
7
Secondary share transfers
4
Funding rounds
3
Disclosed funding
₹20.12 Cr

Deals on record (5 of 7)

WhenDealAmountParties
Jul 2018Funding round₹17.62 CrInvestors: BDR Pharmaceuticals International Private Limited
Mar 2018Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 4 individuals
Aug 2014Funding round₹1.5 CrInvestors: 4 individuals
Mar 2014Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Rikhabji Corporation, 2 individuals
Mar 2010Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 4 individuals

To see the full deal history of Virdev Intermediates Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Virdev Intermediates Private Limited was last rated by Care on 30 Nov 2021.

Rating agencyRated onRating
Care30 Nov 2021

To see the full credit ratings and regulatory alerts of Virdev Intermediates Private Limited, buy the company report.

MSME payment delays

Virdev Intermediates Private Limited has 20 MSME Form 1 returns on record between 2015 and 2023, listing 2,196 overdue payments to 156 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 156)

SupplierAmount dueDue sinceReported on
an individual supplier
Amar Dresses
Surat Ammonia and Chemical Company
an individual supplier
Uni-Tech Valves & Automation

To see the full MSME payment records of Virdev Intermediates Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Virdev Intermediates Private Limited has a workforce of 334 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
334
Active EPFO establishments
1
Employee growth
-5.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27334
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Virdev Intermediates Private Limited, buy the company report.

GST

Virdev Intermediates has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAACV8038L1Z2GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Virdev Intermediates Private Limited, buy the company report.

Recent activity

Virdev Intermediates Private Limited has 9 board changes on record since 1994: 6 appointments and 3 cessations. The latest: Dheer Dharmesh Shah ceased to be Additional Director on 26 Sep 2024.

AGM
Virdev Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Virdev Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Dheer Dharmesh Shah ceased to be Additional Director.
Appointed
Dheer Dharmesh Shah was appointed as Director.
Charges
A charge registered on 27 Mar 2015 via Charge ID 10569075 with Kotak Mahindra Bank Limited was fully satisfied on 14 Sep 2022.
Charges
A charge registered on 31 Jul 2014 via Charge ID 10515182 with Kotak Mahindra Bank Limited was fully satisfied on 14 Sep 2022.
Charges
A charge registered on 18 Jul 2014 via Charge ID 10516190 with Ing Vysya Bank Limited was fully satisfied on 14 Sep 2022.
Ceased
Raheel Dharmesh Shah ceased to be Additional Director.
Ceased
Dharmesh Mahendra Shah ceased to be Director.
Appointed
Raheel Dharmesh Shah was appointed as Director.
Charges
A charge with Kotak Mahindra Bank Limited of Rs. 18.19 Cr registered on 31 Jul 2014 with Charge ID 10515182 was modified on 01 Jul 2015.
Charges
A charge with Kotak Mahindra Bank Limited amounted to Rs. 4.90 Cr with Charge ID 10569075 was registered on 27 Mar 2015.

24 earlier events are in the company report.

Frequently asked questions

Virdev Intermediates is an active private limited company based in Surat, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 01 February 1994 (32+ years old) and is registered under CIN U24230GJ1994PTC021189.

Virdev Intermediates has 6 current directors:

The latest financial statements of Virdev Intermediates on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Virdev Intermediates is 24AAACV8038L1Z2, registered in Gujarat.

The CIN (Corporate Identification Number) of Virdev Intermediates is U24230GJ1994PTC021189. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Virdev Intermediates has 18 court cases on record: 4 filed by the company and 14 filed against it. 3 are pending. Most are in the high courts.

Virdev Intermediates was incorporated on 01 February 1994, making it 32+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Virdev Intermediates has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹20.12 Cr; the latest was in July 2018.

The peers of Virdev Intermediates by revenue are Bakul Pharma Private Limited, Danopharm Private Limited, Almelo Private Limited, Panchsheel Organics Limited, Patel Chem Specialities Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Dheer Dharmesh Shah ceased to be Additional Director on 26 Sep 2024. Dheer Dharmesh Shah was appointed as Director on 01 Mar 2024. Raheel Dharmesh Shah ceased to be Additional Director on 29 Sep 2018. Virdev Intermediates has 9 board changes on record in total.

Yes, Virdev Intermediates is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-22-0001601).

Virdev Intermediates has 20 MSME Form 1 returns on record between 2015 and 2023, listing 2,196 overdue payments to 156 micro and small suppliers. The latest return was filed on 06 Nov 2023.